Cargando…

Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types

Detalles Bibliográficos
Autores principales:	Liu, Zaoqu, Guo, Chunguang, Li, Jing, Xu, Hui, Lu, Taoyuan, Wang, Libo, Liu, Long, Han, Xinwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684773/ https://www.ncbi.nlm.nih.gov/pubmed/34923755 http://dx.doi.org/10.1002/ctm2.619

Ejemplares similares

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma
por: Liu, Zaoqu, et al.
Publicado: (2021)

TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management
por: Liu, Zaoqu, et al.
Publicado: (2021)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy
por: Guo, Chunguang, et al.
Publicado: (2022)

CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis
por: Wang, Libo, et al.
Publicado: (2021)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Inducing multiple nicks promotes interhomolog homologous recombination to correct heterozygous mutations in somatic cells
por: Tomita, Akiko, et al.
Publicado: (2023)

Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
por: Guo, Chunguang, et al.
Publicado: (2022)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients
por: Sugino, Kentaro, et al.
Publicado: (2019)

Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma
por: Li, Pan, et al.
Publicado: (2022)

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
por: Xu, Hui, et al.
Publicado: (2022)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types
por: Shi, Zhiwen, et al.
Publicado: (2023)

Homologous recombination repair gene mutations as a predictive biomarker for immunotherapy in patients with advanced melanoma
por: You, Zhixuan, et al.
Publicado: (2022)

Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment
por: Xu, Hui, et al.
Publicado: (2023)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2023)

Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients
por: Liu, Yixiao, et al.
Publicado: (2023)

Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Homologous recombination occurs frequently at innate GT microsatellites in normal somatic and germ cells in vivo
por: Zheng, Jianbo, et al.
Publicado: (2018)

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Recurrent somatic mutations as predictors of immunotherapy response
por: Gajic, Zoran Z., et al.
Publicado: (2022)

Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer
por: Wang, Libo, et al.
Publicado: (2022)

Immunosenescence: molecular mechanisms and diseases
por: Liu, Zaoqu, et al.
Publicado: (2023)

Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Exploring the roles of intestinal flora in enhanced recovery after surgery
por: Liu, Zaoqu, et al.
Publicado: (2023)

Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
por: Kumar, Runjun D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j7mahghfq0gp0plaknncq3op6c